Daiwa Securities Group’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-360	Closed	-$1K	–	1343
2023 Q3	$1K	Hold	360	–	–	﹤0.01%	1250
2023 Q2	$2K	Hold	360	–	–	﹤0.01%	1230
2023 Q1	$2K	Hold	360	–	–	﹤0.01%	1213
2022 Q4	$4K	Hold	360	–	–	﹤0.01%	1166
2022 Q3	$8K	Hold	360	–	–	﹤0.01%	1138
2022 Q2	$9K	Buy	360 +81	+29%	+$2.23K	﹤0.01%	1144
2022 Q1	$11K	Hold	279	–	–	﹤0.01%	1135
2021 Q4	$16K	Sell	279 -47	-14%	-$2.66K	﹤0.01%	1129
2021 Q3	$19K	Buy	326 +140	+75%	+$11K	﹤0.01%	1107
2021 Q2	$16K	Hold	186	–	–	﹤0.01%	1026
2021 Q1	$15K	Buy	186 +22	+13%	+$2.11K	﹤0.01%	1023
2020 Q4	$15K	Sell	164 -326	-67%	-$20.2K	﹤0.01%	994
2020 Q3	$20K	Buy	490 +80	+20%	+$2.79K	﹤0.01%	991
2020 Q2	$9K	Hold	410	–	–	﹤0.01%	1074
2020 Q1	$9K	Hold	410	–	–	﹤0.01%	1065
2019 Q4	$8K	Hold	410	–	–	﹤0.01%	1081
2019 Q3	$6K	Hold	410	–	–	﹤0.01%	1065
2019 Q2	$8K	Hold	410	–	–	﹤0.01%	1065
2019 Q1	$7K	Sell	410 -140	-25%	-$2.21K	﹤0.01%	1054
2018 Q4	$7K	Buy	+550	New	+$7.67K	﹤0.01%	1028

Other funds holding FATE